切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2026, Vol. 16 ›› Issue (05) : 457 -462. doi: 10.3877/cma.j.issn.2095-2015.2026.05.011

论著

乌四汤加减方在胆总管结石患者腹腔镜联合胆道镜探查取石术胆道一期缝合术后的应用研究
孙太冉1,†(), 吕建东2, 罗冰清1, 席江伟1, 乔舒巍1, 王瑄1   
  1. 1075100 河北张家口,河北北方学院附属第二医院普通外科
    2075100 河北张家口,河北北方学院附属第二医院中医科
  • 收稿日期:2025-06-09 出版日期:2026-10-01
  • 通信作者: 孙太冉
  • 基金资助:
    河北省卫生健康委员会人才培养项目(ZF2023254)

Application of Modified Wusi Decoction in Patients with Choledocholithiasis after Laparoscopic Common Bile Duct Exploration with Primary Suture

Tairan Sun1,†(), Jiandong Lyu2, Bingqing Luo1, Jiangwei Xi1, Shuwei Qiao1, Xuan Wang1   

  1. 1General Surgery Department, Second Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei 075100
    2Department of Traditional Chinese Medicine, Second Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei 075100
  • Received:2025-06-09 Published:2026-10-01
  • Corresponding author: Tairan Sun
引用本文:

孙太冉, 吕建东, 罗冰清, 席江伟, 乔舒巍, 王瑄. 乌四汤加减方在胆总管结石患者腹腔镜联合胆道镜探查取石术胆道一期缝合术后的应用研究[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(05): 457-462.

Tairan Sun, Jiandong Lyu, Bingqing Luo, Jiangwei Xi, Shuwei Qiao, Xuan Wang. Application of Modified Wusi Decoction in Patients with Choledocholithiasis after Laparoscopic Common Bile Duct Exploration with Primary Suture[J/OL]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2026, 16(05): 457-462.

目的

探讨在腹腔镜联合胆道镜探查取石术及胆道一期缝合术后,加服乌四汤加减方对胆总管结石患者术后恢复、并发症、中医证候及临床疗效的影响。

方法

采用前瞻性随机对照研究,连续纳入2019年1月至2024年12月于河北北方学院附属第二医院确诊为胆总管结石并接受手术治疗的98例患者,按随机数字表法分为观察组与对照组,各49例。对照组术后接受常规抗感染、保肝及对症支持治疗;观察组在对照组基础上,于术后肛门恢复排气后加服我院自制乌四汤加减方,每次125 mL,每日两次,连续服用2周。比较两组患者的围手术期指标、术后并发症、中医证候评分、术后机能恢复情况及临床总体疗效。

结果

观察组术后下床活动时间显著短于对照组,术中出血量明显减少(P<0.05)。观察组术后总并发症发生率(6.12%)显著低于对照组(16.33%),且无残余结石病例(P<0.05)。观察组在术后腹痛、腹胀、食欲减退等各项中医证候评分上均显著低于对照组(P<0.05)。观察组术后肝功能指标[总胆红素(TBIL)、直接胆红素(DBIL)、谷丙转氨酶(ALT)和谷草转氨酶(AST)]改善更优,肠道功能恢复时间、术后首次进食时间更短,术后24 h疼痛评分及镇痛药使用量均显著低于对照组(P<0.05)。观察组临床总有效率为100.00%,显著高于对照组的83.67%(P<0.05)。

结论

在腹腔镜联合胆道镜胆总管探查取石一期缝合术后应用乌四汤加减方,能够有效促进患者术后恢复,降低并发症发生率,显著改善中医证候与肝功能,减轻术后疼痛,提高临床总体疗效,是一种安全有效的中西医结合治疗方案。

Objective

To investigate the effects of postoperative administration of Modified Wusi Decoction on postoperative recovery, complications, Traditional Chinese Medicine (TCM) syndromes, and clinical efficacy in patients with choledocholithiasis following laparoscopic common bile duct exploration with primary suture.

Methods

A prospective randomized controlled trial was conducted. A total of 98 patients diagnosed with choledocholithiasis who underwent surgical treatment at our hospital from January 2019 to December 2024 were continuously enrolled and randomly divided into the observation group (n=49) and the control group (n=49) using a random number table. The control group received routine postoperative care, including anti-infection, liver protection, and symptomatic supportive therapy. The observation group received self-made Modified Wusi Decoction in addition to the routine care, starting after the recovery of anal exhaust. The decoction was administered at 125 mL per dose, twice daily, for two consecutive weeks. Perioperative indicators, postoperative complications, TCM symptom scores, postoperative functional recovery, and overall clinical efficacy were compared between the two groups.

Results

The time to first ambulation was significantly shorter and intraoperative blood loss was significantly lower in the observation group than in the control group (P<0.05). The total incidence of postoperative complications in the observation group (6.12%) was significantly lower than that in the control group (16.33%), with no cases of residual stones in the observation group (P<0.05). Scores for TCM symptoms such as postoperative abdominal pain, bloating, and loss of appetite were all significantly lower in the observation group (P<0.05). The observation group showed greater improvement in liver function indicators (Total Bilirubin (TBIL), Direct Bilirubin (DBIL), Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST)), shorter time to intestinal function recovery and first postoperative feeding, and significantly lower 24-hour postoperative pain scores and analgesic consumption compared to the control group (P<0.05). The total clinical effective rate was 100.00% in the observation group, significantly higher than the 83.67% in the control group (P<0.05).

Conclusion

The application of Modified Wusi Decoction following laparoscopic common bile duct exploration with primary suture can effectively promote postoperative recovery, reduce the incidence of complications, significantly improve TCM syndromes and liver function, alleviate postoperative pain, and enhance overall clinical efficacy. It represents a safe and effective therapeutic strategy integrating Chinese and Western medicine.

表1 两组胆总管结石患者基线资料对比
表2 两组胆总管结石患者围手术期指标对比(±s)
表3 两组胆总管结石患者术后并发症发生率对比[例(%)]
表4 两组胆总管结石患者中医证候评分对比(±s)
表5 两组胆总管结石患者术后机能恢复指标对比(±s)
表6 两组胆总管结石患者临床疗效对比[例(%)]
[1]
张井虹, 尚海涛, 刘军舰, 等. 腹腔镜胆总管一期缝合与内镜取石治疗继发性胆总管结石的临床疗效比较[J]. 中国普通外科杂志, 2021, 30(8): 877-885.
[2]
朱洪江, 梅永. 腹腔镜下沿胆囊管切开胆道探查一期缝合治疗胆总管结石的疗效观察[J]. 腹腔镜外科杂志, 2025, 30(4): 269-272.
[3]
张琦, 于庆生, 汪玲虎, 等. 腹腔镜、胆道镜联合序贯中药治疗肝外胆管结石术后肝郁脾虚证40例[J]. 安徽中医药大学学报, 2022, 41(6): 33-38.
[4]
舒亚倩, 张琦, 齐伟, 等. ERCP联合EPBD序贯中药治疗肝外胆管结石术后肝郁气滞型患者60例临床观察[J]. 中医药临床杂志, 2025, 37(2): 374-379.
[5]
孙太冉, 吕建东, 席江伟, 等. 乌四汤辅助腹腔镜联合胆道镜探查取石术后一期缝合术治疗难治性胆总管结石临床观察[J]. 中国药业, 2025, 34(17): 114-117.
[6]
国家药品监督管理局药品审评中心. 中药新药临床研究指导原则(2022年版)[M]. 北京: 中国医药科技出版社, 2022: 456-462.
[7]
李建军, 马晓飞, 刘琪, 等. 双镜联合钬激光行胆道探查取石+一期缝合在有腹部手术史肝内外胆管结石患者中的应用[J]. 肝胆胰外科杂志, 2021, 33(2): 106-109.
[8]
Ma Z, Zhou J, Yao L, et al. Safety and efficacy of laparoscopic common bile duct exploration for the patients with difficult biliary stones: 8 years of experiences at a single institution and literature review[J]. Surg Endosc, 2022, 36(1): 718-727.
[9]
Yin Y, He K, Xia X. Comparison of Primary Suture and T-Tube Drainage After Laparoscopic Common Bile Duct Exploration Combined with Intraoperative Choledochoscopy in the Treatment of Secondary Common Bile Duct Stones: A Single-Center Retrospective Analysis[J]. J Laparoendosc Adv Surg Tech A, 2022, 32(6): 612-619.
[10]
Luo T, Huang Y, Wang S, et al. Laparoscopic common bile duct exploration with primary closure is preferred for selected elderly individuals with choledocholithiasis[J]. Ann Gastroenterol Surg, 2023, 7(5): 772-783.
[11]
中国中西医结合学会消化系统疾病专业委员会, 毛堂友, 姚树坤, 等. 胆石症中西医结合诊疗专家共识(2025年)[J]. 中国中西医结合消化杂志, 2025, 33(3): 242-251.
[12]
Zhang Z, Shao G, Li Y, et al. Efficacy and safety of laparoscopic common bile duct exploration with primary closure and intraoperative endoscopic nasobiliary drainage for choledocholithiasis combined with cholecystolithiasis[J]. Surg Endosc, 2023, 37(3): 1700-1709.
[13]
张桂信, 杨琦, 杨阳, 等. 基于"胆腑以通为用"理论的胆石症治疗机制及临床研究进展[J]. 湖北中医药大学学报, 2025, 27(5): 121-124.
[14]
赵烨烨. 乌梅汤加减治疗胆汁反流性胃炎寒热错杂型的疗效分析[J]. 检验医学与临床, 2016, 13(z2): 295-296.
[15]
张艳东, 吕建东, 王振苗, 等. 乌梅丸联合四逆散加减辅助治疗急性结石性胆囊炎术后临床观察[J]. 中国中医急症, 2025, 34(1): 130-133.
[16]
翟建宁, 金小晶, 胡胜红. 四逆散合左金丸加减对肝胃不和证老年难治性胃食管反流病患者的临床疗效[J]. 中成药, 2024, 46(10): 3536-3539.
[17]
衣珊, 赵海滨, 吴春博. 四逆散合养心汤治疗经皮冠状动脉介入术后合并抑郁状态的回顾性研究[J]. 广州中医药大学学报, 2023, 40(4): 813-819.
[18]
吕建东, 王伟, 孙太冉, 等. 乌梅丸合四逆散加减方治疗胆结石微创术后患者的疗效及对患者胆囊功能、炎性因子的影响[J]. 中医药学报, 2025, 53(5): 102-106.
[19]
毛艳平, 张能平. 利胆排石汤辅助胆道镜取石术治疗慢性胆囊炎合并胆结石疗效及对胆汁成石成分、炎性细胞因子的影响[J]. 现代中西医结合杂志, 2019, 28(4): 406-408.
[20]
郭彪彪, 党志博, 李梦阁, 等. 基于"态靶理论"分析党中勤教授治疗"湿热瘀阻型"胆石症的经验[J]. 中西医结合肝病杂志, 2025, 35(10): 1306-1310.
[1] 唐悦, 葛晓明, 邓凯元, 杨剑. 全3D腹腔镜下可切除性胃癌术中非离断式Roux-en-Y吻合在消化道重建中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(05): 432-436.
[2] 陶发明, 麦麦提依明, 巴穆登, 陈映君, 吴朝阳. 胆总管结石腹腔镜一期缝合与T管引流比较[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(05): 443-446.
[3] 朵红梅, 冶成贵. 基于PSM分析高原地区胆囊结石合并胆总管结石急诊与择期手术的预后[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(05): 447-451.
[4] 王彬宇, 钱江, 徐超. 腹腔镜联合超细胆道镜治疗胆总管结石合并胆囊结石的临床疗效[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(05): 452-456.
[5] 郭建辉, 陈小炎, 胡鹏, 王辰啸, 陈华涛, 闵凯, 吴彪. 腹腔镜下腹壁切口疝人工合成防粘连补片修补术后肠梗阻的危险因素分析及防治措施[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(05): 457-462.
[6] 刘宝平, 徐爱忠. 腹腔镜经腹膜外疝修补术中轻量聚丙烯补片与自固定补片的临床效果对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(05): 485-489.
[7] 孙毅, 訾力, 公绪飞, 郭明晓. 多原发胃肠道恶性肿瘤序贯治疗:1例报告并文献复习[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(05): 504-506.
[8] 李思江, 谭秋林, 周伟. 后腹腔镜肾部分切除术十步法运用技巧及总结[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(05): 561-565.
[9] 刘立民, 张宗明, 刘卓. 胆总管结石合并胆囊结石的腹腔镜、胆道镜及内镜联合治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(05): 692-701.
[10] 罗佳, 韩江, 戴已禾, 晋云. 单孔腹腔镜术中超声引导下微波消融在肝脏肿瘤中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(05): 724-730.
[11] 郑海明, 廖祥伟, 黎文华, 翟颖, 郭阳, 周尊强, 宛新建. ERCP下胆管及胆囊内引流治疗急性胆囊炎合并胆管炎疗效及其预测模型构建[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(05): 750-759.
[12] 彭吒, 王亚琼, 何承益, 黄海. LC联合LTCBDE一期缝合在胆囊结石合并胆总管结石ERCP取石失败患者中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(05): 768-776.
[13] 汪韬, 潘炳权, 郁林海. 经脐入路三通道腹腔镜胆囊切除术的安全性与疗效分析:附10 000例报告[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(05): 791-797.
[14] 王文超, 王超群, 朱文伟, 陆录, 汤旻, 殷保兵. LC联合肝楔形切除术在术前高度疑似胆囊癌患者中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(05): 798-805.
[15] 张胜龙, 叶俊, 杨志强. 单孔LC联合LCBDE、胆道支架置入一期缝合治疗胆囊结石合并胆总管结石疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(05): 806-811.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?